About
Mapping and ablation solution suite for the treatment of atrial fibrillation
Areas of Focus
Categories
Surgical DeviceUncategorized Medical DeviceBiotech
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
510
By Phase
NA: 2
By Status
COMPLETED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05883631Lead Sponsor
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
NAActive, not recruiting
400 participants
Started: Oct 23, 2023 · Completed: Jan 31, 2026
NCT05481359Collaborator
AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation
N/ACompleted
25 participants
Started: Sep 12, 2022 · Completed: Nov 17, 2023
NCT04473963Lead Sponsor
FLOW-AF: A Study to Evaluate Electrographic Flow™ (EGF) Mapping Technology
NACompleted
85 participants
Started: Sep 27, 2019 · Completed: Sep 27, 2021
Locations (1)
Headquarters
Santa Clara, CA, United States
Map
Loading map...